Chopas James George 4
4 · Apellis Pharmaceuticals, Inc. · Filed Oct 24, 2023
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Sale
Common Stock
2023-10-23$46.04/sh−132$6,077→ 32,680 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on a Restricted Stock Unit release.